InvestSMART

Atomo Diagnostics Limited (ASX:AT1)

ALERT: Price-sensitive ASX Announcement for AT1
Current share price for AT1 : $0.018 -0.013 (-41.67%)+
Announcement
Release
24 Sep 2025 3:32PM
Price at Release
$0.030
Full Release
download
Summary
Atomo Diagnostics Limited (AT1) received a price query from the ASX due to a notable increase in its securities' price and trading volume. In response, the company confirmed it was unaware of any undisclosed price-sensitive information that could explain the recent trading activity. AT1 attributed the trading activity to a recent purchase order for 65,000 HIV Self Test Kits for Ukraine, funded by USAID, which was not announced as it was below the company's materiality threshold. The company assured compliance with the ASX Listing Rules, particularly Listing Rule 3.1, and confirmed that its responses were authorized by its Board.
Key Points
  • ASX queried AT1 on recent securities' price and volume changes.
  • AT1 unaware of any undisclosed price-sensitive information.
  • Recent purchase order for HIV Self Test Kits attributed to trading activity.
  • Order valued below materiality threshold, not announced on ASX.
  • Company complies with ASX Listing Rules, especially Listing Rule 3.1.
  • Responses authorized by the Board of Atomo Diagnostics.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.